Leukemia
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Leukemia is a peer-reviewed medical journal published by the Nature Publishing Group. It was established in 1987 by Nicole Muller-Bérat Killman and Sven-Aage Killman, and is currently edited by Professors Andreas Hochhaus and Robert Peter Gale. The journal covers research on all aspects of leukemia and has a 2019 impact factor of 8.665. Less
Key Metrics
View Chart Journal Specifications
- PublisherSPRINGERNATURE
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1987
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 22% |
| 4-6 | 45% |
| 7-9 | 24% |
| >9 | 9% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Leukemia been publishing? 
The Leukemia has been publishing since 1987 till date.
How frequently is the Leukemia published?
Leukemia is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Leukemia?
Leukemia has a H-index score of 211, Citescore of 17.6, SNIP score of 2.69, & SJR of Q1
Who is the publisher of Leukemia?
The publisher of Leukemia is SPRINGERNATURE.
Where can I find a journal's aims and scope of Leukemia?
For the Leukemia's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Leukemia on editage?
For the Leukemia metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Leukemia?
The eISSN number is 1476-5551 and pISSN number is 0887-6924 for Leukemia.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Germline, Overall survival, Minimal residual disease, Antibody response, Bone marrow, Myeloid leukemia, Poor prognosis, Hematopoietic stem cell transplantation, Cytarabine, Lenalidomide, Tyrosine kinase, B-cell lymphoma, Hematopoietic stem cell, Nilotinib, Serum protein, B-cell acute lymphoblastic leukemia, Genome, Conventional treatment, Rituximab, Hematologic Neoplasms.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.